Article info

Download PDFPDF
Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2)

Authors

  1. Correspondence to Dr Mohamed Tarek M Shata, Viral Immunology Laboratory, Department of Internal Medicine, Division of Digestive Diseases, University of Cincinnati Medical Center, 231 Albert B. Sabin Way, MSB 6360, Cincinnati, OH 45267-0595, USA; mohamed.shata{at}uc.edu
View Full Text

Citation

Shata MTM, Abdel-Hameed EA, Hetta HF, et al
Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2)

Publication history

  • Received February 26, 2013
  • Revised May 28, 2013
  • Accepted June 13, 2013
  • First published August 12, 2013.
Online issue publication 
October 31, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.